DOCSLIB.ORG

040496 Knockout Mice

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
040496 Knockout Mice 904 THE NEW ENGLAND JOURNAL OF MEDICINE April 4, 1996 MOLECULAR MEDICINE haploid genome can be passed on to subsequent gen- erations. KNOCKOUT MICE The goal of the gene-targeting (knockout) method is to replace the specific gene of interest with one that is JOSEPH A. MAJZOUB, M.D., inactive, altered, or irrelevant. To increase the probabil- AND LOUIS J. MUGLIA, M.D., PH.D. ity that such replacement will occur, rather than non- specific random integration of the DNA, both ends of the HE ability to remove or alter with precision a sin- replacement gene are flanked by long DNA sequences Tgle one of the thousands of genes in the body and homologous to the sequences flanking the target gene to transmit this mutation to all subsequent progeny was (Fig. 1). Gene constructs of this type permit corre- a science-fiction dream only a few years ago. But today sponding stretches of DNA to be exchanged (in what is this technique is part of a routine procedure for creat- termed “homologous recombination”) when the DNA ing animal models that can be used to study the patho- breaks and rejoins. The frequency of homologous re- physiology and therapy of diseases in humans. combination is low. Therefore, there must be a way of In general, mutations that cause a gain of function selecting the rare cells in which the target gene has been produce disease even when they occur in only one of a replaced by the constructed gene. Two selectable mark- gene’s two alleles; for example, the oncogenic muta- ers meet this purpose. tions that cause abnormal cell proliferation. In a reces- Figure 1 shows the use of selectable markers in an sive genetic disorder, by contrast, there must be muta- experiment using a genetically engineered knockout tions in both alleles for the disease to be produced, and vector to inactivate the gene that encodes corticotropin- the mutations cause a loss of function; for example, in releasing hormone (CRH) in mice. The vector was cre- patients with cystic fibrosis two copies of a recessive al- ated by replacing the gene encoding the CRH polypep- lele cause a loss of chloride-channel activity. tide with a gene that confers resistance to the antibiotic The methods needed to produce animal models of neomycin. This bacterial gene lies between the 59 and recessive genetic diseases differ from those used in study- the 39 homologous flanking regions present in both the ing autosomal dominant diseases. Integrating an onco- target and the replacement gene. The knockout vec- gene that causes dominant disease, such as c-myc, into tor also contains a gene that encodes viral thymidine the genome of a fertilized mouse oocyte without alter- kinase, which confers sensitivity to ganciclovir. This ing the mouse’s own genes creates a transgenic, cancer- second selectable marker lies outside the 59 and 39 ho- prone mouse that transmits this trait to its offspring mologous flanking regions of the replacement gene. with a dominant pattern of inheritance. To create an an- The genetically engineered DNA is introduced into imal model of an autosomal recessive disease, however, embryonic stem cells that are then incubated with tis- both alleles of the normal gene must be inactivated. sue-culture medium containing neomycin and ganciclo- The technique of gene “knockout” was developed for this purpose. Several independent scientific advances have cul- Figure 1. Homologous Recombination between a Cellular Gene minated in the ability to alter a single heritable gene in and a Knockout Vector to Create Mice Lacking Corticotropin- the DNA of a mouse with precision. Initially, chimer- Releasing Hormone (CRH), a Major Hypothalamic Regulator of ic mice with somatic cells from more than one genetic the Stress Response. background were created, though inefficiently, by intro- Embryonic stem cells (upper left-hand panel) contain the CRH cellular gene (upper right-hand panel), which consists of exon ducing embryonal carcinoma cells into normal mouse 1 (olive green, a 59 noncoding region), an intron, and exon 2 (red, embryos early in gestation. In the early 1980s, the ef- a protein-coding region, and yellow, a 39 noncoding region). A ficiency of the process used to generate chimeras im- knockout vector, consisting of a collinear assembly of a DNA proved markedly when methods were developed to flanking segment 59 to the cellular gene (blue), the phosphoglyc- culture totipotential cells from the inner cell mass of erate kinase–bacterial neomycin gene (pgk-neo, violet), a 39 seg- ment of the cellular gene (yellow), a DNA flanking segment 39 to the blastocyst, the area destined to become the fetus. the cellular gene (green), and the phosphoglycerate kinase–viral These pluripotential cells, termed embryonic stem cells, thymidine kinase gene (pgk-tk, orange), is created and introduced can be genetically altered and then microinjected into into the embryonic-stem-cell culture. Double recombination oc- the cavity of an intact mouse blastocyst after 3.5 (of a curs between the cellular gene and the knockout vector in the 59 homologous regions and the 39 homologous regions (dashed total of 19.5) days of gestation. They can, from the lines), resulting in the incorporation of the inactive knockout vec- blastocyst stage, populate all the tissues of the develop- tor, including pgk-neo but not pgk-tk, into the cellular genomic lo- ing mouse. The contribution of the embryonic stem cus of the embryonic stem cell. The presence of pgk-neo and the cells to the genetic makeup of the chimeric animal that absence of pgk-tk in these replaced genes will allow survival of develops from the injected blastocyst is most easily as- these embryonic stem cells after positive–negative selection with neomycin and ganciclovir (see text). sessed by using embryonic stem cells and blastocysts In the bottom panel, the clone of mutant embryonic stem cells is whose genes for coat color differ. If the embryonic stem injected into a host blastocyst, which is implanted into a pseu- cells contribute to the germ cells (for example, the dopregnant foster mother, and subsequently develops into a chi- sperm) of the developing mouse embryo, their entire meric offspring. The contribution of the embryonic stem cells to the germ cells of the chimeric mouse results in germ-line trans- mission of the embryonic-stem-cell genome to offspring that are From the Division of Endocrinology, Children’s Hospital, Harvard Medical heterozygous for the mutated CRH allele. The heterozygotes are School, Boston. mated to produce mutant mice homozygous for CRH deficiency, 1996, Massachusetts Medical Society. with impaired hormonal responses to multiple stressors. This document was created with FrameMaker 4 0 4 Vol. 334 No. 14 MOLECULAR MEDICINE 905 vir. Embryonic stem cells that have incorporated the outside the region of specific homologous recombina- new DNA by homologous recombination resist neo- tion (negative selection). mycin (positive selection). By contrast, cells that have In embryonic stem cells that survived this “positive– nonspecifically taken up genetically engineered DNA, negative” selection, the CRH knockout vector had cor- including the viral thymidine kinase, are killed by ganci- rectly replaced one of the normal CRH alleles. These clovir because of the gene for this kinase, which lies clones were then injected into blastocysts to initiate the Embryonic stem cell CRH gene 59 homologous Intron 39 homologous region region Cellular gene Embryonic-stem- cell culture Plasmid Homologous pgk-neo pgk-tk DNA recombination Knockout vector Cellular gene replaced Selection by neomycin and ganciclovir Injection of Implantation of chimeric embryonic stem cells blastocyst in foster mother into host blastocyst Germ-line offspring Chimeric offspring 906 THE NEW ENGLAND JOURNAL OF MEDICINE April 4, 1996 creation of chimeric mice (Fig. 1). Chimeras with germ Table1. Human Disorders Studied in Knockout Mice. cells derived from the altered embryonic stem cells trans- mitted the changed embryonic-stem-cell genome to their DISORDER TARGET MOUSE GENE OR GENE PRODUCT offspring, yielding mice heterozygous for CRH deficien- Cardiology cy; the heterozygotes were then bred to each other to Atherosclerosis Apolipoprotein E, low-density–lipo- protein receptor create mice homozygous for CRH deficiency. Salt-sensitive hypertension Atrial natriuretic peptide The deficits present in a knockout mouse can reveal Endocrinology or clarify the function of the mutant gene. The analysis Familial hypocalciuric hypercalcemia Calcium receptor by targeted inactivation of the genes implicated in fetal Glycogen storage disease type 1 Glucose-6-phosphatase development and organogenesis has been especially pow- Intrauterine growth retardation Insulin-like growth factor II Obesity b -Adrenergic receptor erful. Gene knockout has shown that the gene SF-1 3 (encoding steroidogenic factor 1) is essential for adrenal Gastroenterology Hirschsprung’s disease Endothelin receptor and gonadal organogenesis. Also essential are WT-1 Ulcerative colitis Interleukin-2 (the Wilms’ tumor locus), for renal development, and the Hematology genes encoding myogenin (for skeletal-muscle forma- a-Thalassemia a-Globin tion), the glucocorticoid receptor (for glucocorticoid- Hemophilia A Factor VIII mediated fetal development), and the estrogen receptor Chronic granulomatous disease Cytochrome b-245 (for female sexual maturation). RAG-2 (recombination- Immunology Autoimmune lymphoproliferative syn- FAS activating gene 2) and GATA-1 (which recognizes a drome GATA-nucleotide motif) are critical to the development
Load more

Recommended publications
  • Research Article Gene Knockout Identification Using an Extension of Bees Hill Flux Balance Analysis
    Hindawi Publishing Corporation BioMed Research International Volume 2015, Article ID 124537, 10 pages http://dx.doi.org/10.1155/2015/124537 Research Article Gene Knockout Identification Using an Extension of Bees Hill Flux Balance Analysis Yee Wen Choon,1 Mohd Saberi Mohamad,1 Safaai Deris,1 Chuii Khim Chong,1 Sigeru Omatu,2 and Juan Manuel Corchado3 1 Artificial Intelligence and Bioinformatics Research Group, Faculty of Computing, Universiti Teknologi Malaysia, 81310 Skudai, Johor, Malaysia 2 Department of Electronics, Information and Communication Engineering, Osaka Institute of Technology, Osaka 535-8585, Japan 3 Biomedical Research Institute of Salamanca/BISITE Research Group, University of Salamanca, 37008 Salamanca, Spain Correspondence should be addressed to Mohd Saberi Mohamad; [email protected] Received 21 August 2014; Revised 22 October 2014; Accepted 31 October 2014 Academic Editor: Juan F. De Paz Copyright © 2015 Yee Wen Choon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Microbial strain optimisation for the overproduction of a desired phenotype has been a popular topic in recent years. Gene knockout is a genetic engineering technique that can modify the metabolism of microbial cells to obtain desirable phenotypes. Optimisation algorithms have been developed to identify the effects of gene knockout. However, the complexities of metabolic networks have made the process of identifying the effects of genetic modification on desirable phenotypes challenging. Furthermore, a vast number of reactions in cellular metabolism often lead to a combinatorial problem in obtaining optimal gene knockout.
    [Show full text]
  • Gene Editing of Microalgae: Scientific Progress and Regulatory
    biology Review Gene Editing of Microalgae: Scientific Progress and Regulatory Challenges in Europe Andrew Spicer 1,* and Attila Molnar 2 ID 1 Algenuity, Eden Laboratory, Bedfordshire MK43 9ND, UK 2 Institute of Molecular Plant Sciences, University of Edinburgh, Edinburgh EH9 3BF, UK; [email protected] * Correspondence: [email protected]; Tel.: +44-1234-765773 Received: 22 December 2017; Accepted: 1 March 2018; Published: 6 March 2018 Abstract: It is abundantly clear that the development of gene editing technologies, represents a potentially powerful force for good with regard to human and animal health and addressing the challenges we continue to face in a growing global population. This now includes the development of approaches to modify microalgal strains for potential improvements in productivity, robustness, harvestability, processability, nutritional composition, and application. The rapid emergence and ongoing developments in this area demand a timely review and revision of the current definitions and regulations around genetically modified organisms (GMOs), particularly within Europe. Current practices within the EU provide exemptions from the GMO directives for organisms, including crop plants and micro-organisms that are produced through chemical or UV/radiation mutagenesis. However, organisms generated through gene editing, including microalgae, where only genetic changes in native genes are made, remain currently under the GMO umbrella; they are, as such, excluded from practical and commercial opportunities in the EU. In this review, we will review the advances that are being made in the area of gene editing in microalgae and the impact of regulation on commercial advances in this area with consideration to the current regulatory framework as it relates to GMOs including GM microalgae in Europe.
    [Show full text]
  • What Are Knockout Mice?
    Lecture 37 Knockout mice Lecture 29 Cloning and Expression vectors Lecture 30 Eukaryotic Protein Expression Systems –I Lecture 31 Eukaryotic Protein Expression Systems –II Lecture 32 Eukaryotic Protein Expression Systems –III Lecture 33 Human Gene Therapy Lecture 34 DNA Vaccines Lecture 35 Transgenic Animals Lecture 36 Transgenic Plants Lecture 37 Knockout Mice What are knockout mice? A knockout mouse is a mouse in which a specific gene has been inactivated or “knocked out” by replacing it or disrupting it with an artificial piece of DNA. The loss of gene activity often causes changes in a mouse's phenotype and thus provides valuable information on the function of the gene. Researchers who developed the technology for the creation of knockout mice won Nobel Prize in the year 2007 The Nobel Prize in Physiology or Medicine 2007 was awarded jointly to Mario R. Capecchi, Sir Martin J. Evans and Oliver Smithies "for their discoveries of principles for introducing specific gene modifications in mice by the use of embryonic stem cells". Mario R. Capecchi Sir Martin J. Evans Oliver Smithies The ability to delete or mutate any gene of interest in mice has transformed the landscape of mammalian biology research. Cultivation of embryonic stem (ES) cells – Martin Evans • Gene targeting – Oliver Smithies • Gene knockout – Mario Capecchi Gene correction by Oliver Smithies Targeted correction of a mutant HPRT gene in mouse ES cells. Nature 330:576-8, 1987 This modification of a chosen gene in pluripotent ES cells demonstrates the feasibility of this route to manipulating mammalian genomes in predetermined ways. -------------------------------------------------------------------------------------- Nature. 1985 Sep 19-25;317(6034):230-4.
    [Show full text]
  • The Human Genome Project Focus of the Human Genome Project
    TOOLS OF GENETIC RESEARCH THE HUMAN GENOME PROJECT FOCUS OF THE HUMAN GENOME PROJECT The primary work of the Human Genome Project has been to Francis S. Collins, M.D., Ph.D.; produce three main research tools that will allow investigators to and Leslie Fink identify genes involved in normal biology as well as in both rare and common diseases. These tools are known as positional cloning The Human Genome Project is an ambitious research effort aimed at deciphering the chemical makeup of the entire human (Collins 1992). These advanced techniques enable researchers to ge ne tic cod e (i.e. , the g enome). The primary wor k of the search for disease­linked genes directly in the genome without first having to identify the gene’s protein product or function. (See p ro j e c t i s t o d ev e lop t h r e e r e s e a r c h tool s t h a t w i ll a ll o w the article by Goate, pp. 217–220.) Since 1986, when researchers scientists to identify genes involved in both rare and common 2 diseases. Another project priority is to examine the ethical, first found the gene for chronic granulomatous disease through legal, and social implications of new genetic technologies and positional cloning, this technique has led to the isolation of consid­ to educate the public about these issues. Although it has been erably more than 40 disease­linked genes and will allow the identi­ in existence for less than 6 years, the Human Genome Project fication of many more genes in the future (table 1).
    [Show full text]
  • Step-By-Step Knockout (Dsdna) Protocol.Pdf
    Court Lab Protocol 3/21/11 Recombineering: Using Drug Cassettes to Knock out Genes in vivo James A. Sawitzke1, Lynn C. Thomason2, Mikhail Bubunenko1,2, Xintian Li1, Nina Costantino1, and Donald L. Court1 1Molecular Control and Genetics Section, Gene Regulation and Chromosome Biology Laboratory, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702 2Gene Regulation and Chromosome Biology Laboratory, Basic Science Program, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD 21702 Purpose A “gene knockout” or “knockout” is a mutation that inactivates a gene function. These mutations are very useful for classical genetic studies as well as for modern techniques including functional genomics. In the past, knockouts of bacterial genes were often made by transposon mutagenesis. In this case, laborious screens are required to find a knockout in the gene of interest. Knockouts of other organisms have traditionally been made by first using in vitro genetic engineering to modify genes contained on plasmids or Bacterial Artificial Chromosomes (BACs) and later moving these modified constructs to the organism of interest by cell culture techniques. Other methods utilizing a combination of genetic engineering and in vivo homologous recombination were inefficient at best. Recombineering provides a new way to generate knockout mutations directly on the bacterial chromosome or to modify any plasmid or BAC in vivo as a prelude to making knockouts in other organisms. The constructs are designed to the base pair and are not dependent on suitable restriction sites. A drug cassette can be placed anywhere within a gene or the open reading of the gene can be replaced with the drug cassette.
    [Show full text]
  • Generation of Mouse Conditional Knockout Alleles in One Step Using the I-GONAD Method
    Downloaded from genome.cshlp.org on September 29, 2021 - Published by Cold Spring Harbor Laboratory Press Method Generation of mouse conditional knockout alleles in one step using the i-GONAD method Renjie Shang,1,2 Haifeng Zhang,1 and Pengpeng Bi1,2 1Center for Molecular Medicine, University of Georgia, Athens, Georgia 30602, USA; 2Department of Genetics, University of Georgia, Athens, Georgia 30602, USA The Cre/loxP system is a powerful tool for gene function study in vivo. Regulated expression of Cre recombinase mediates precise deletion of genetic elements in a spatially– and temporally–controlled manner. Despite the robustness of this system, it requires a great amount of effort to create a conditional knockout model for each individual gene of interest where two loxP sites must be simultaneously inserted in cis. The current undertaking involves labor-intensive embryonic stem (ES) cell– based gene targeting and tedious micromanipulations of mouse embryos. The complexity of this workflow poses formida- ble technical challenges, thus limiting wider applications of conditional genetics. Here, we report an alternative approach to generate mouse loxP alleles by integrating a unique design of CRISPR donor with the new oviduct electroporation technique i-GONAD. Showing the potential and simplicity of this method, we created floxed alleles for five genes in one attempt with relatively low costs and a minimal equipment setup. In addition to the conditional alleles, constitutive knockout alleles were also obtained as byproducts of these experiments. Therefore, the wider applications of i-GONAD may promote gene func- tion studies using novel murine models. [Supplemental material is available for this article.] Our understanding of the genetic mechanisms of human diseases strains are readily available, generation of the loxP-flanked (floxed) has been largely expanded by loss-of-function studies using engi- alleles is challenging and labor-intensive due to the lack of an effi- neered mouse models.
    [Show full text]
  • Prospects of Gene Knockouts in the Functional Study of MAMP-Triggered Immunity: a Review
    International Journal of Molecular Sciences Review Prospects of Gene Knockouts in the Functional Study of MAMP-Triggered Immunity: A Review Benedict C. Offor , Ian A. Dubery and Lizelle A. Piater * Department of Biochemistry, University of Johannesburg, Auckland Park 2006, South Africa; benedictoff[email protected] (B.C.O.); [email protected] (I.A.D.) * Correspondence: [email protected]; Tel.: +27-11-559-2403 Received: 5 March 2020; Accepted: 1 April 2020; Published: 6 April 2020 Abstract: Plants depend on both preformed and inducible defence responses to defend themselves against biotic stresses stemming from pathogen attacks. In this regard, plants perceive pathogenic threats from the environment through pattern recognition receptors (PRRs) that recognise microbe-associated molecular patterns (MAMPs), and so induce plant defence responses against invading pathogens. Close to thirty PRR proteins have been identified in plants, however, the molecular mechanisms underlying MAMP perception by these receptors/receptor complexes are not fully understood. As such, knockout (KO) of genes that code for PRRs and co-receptors/defence-associated proteins is a valuable tool to study plant immunity. The loss of gene activity often causes changes in the phenotype of the model plant, allowing in vivo studies of gene function and associated biological mechanisms. Here, we review the functions of selected PRRs, brassinosteroid insensitive 1 (BRI1) associated receptor kinase 1 (BAK1) and other associated defence proteins that have been identified in plants, and also outline KO lines generated by T-DNA insertional mutagenesis as well as the effect on MAMP perception—and triggered immunity (MTI). In addition, we further review the role of membrane raft domains in flg22-induced MTI in Arabidopsis, due to the vital role in the activation of several proteins that are part of the membrane raft domain theory in this regard.
    [Show full text]
  • Generation of Knockout Mouse Models of Cyclin-Dependent Kinase Inhibitors by Engineered Nuclease-Mediated Genome Editing
    ISSN 1738-6055 (Print) ISSN 2233-7660 (Online) Lab Anim Res 2018: 34(4), 264-269 https://doi.org/10.5625/lar.2018.34.4.264 Generation of knockout mouse models of cyclin-dependent kinase inhibitors by engineered nuclease-mediated genome editing Bo Min Park, Jae-il Roh*, Jaehoon Lee*, Han-Woong Lee* Department of Biochemistry, College of Life Science & Biotechnology, Yonsei University, Seoul, Korea Cell cycle dysfunction can cause severe diseases, including neurodegenerative disease and cancer. Mutations in cyclin-dependent kinase inhibitors controlling the G1 phase of the cell cycle are prevalent in various cancers. Mice lacking the tumor suppressors p16Ink4a (Cdkn2a, cyclin-dependent kinase inhibitor 2a), p19Arf (an alternative reading frame product of Cdkn2a,), and p27Kip1 (Cdkn1b, cyclin-dependent kinase inhibitor 1b) result in malignant progression of epithelial cancers, sarcomas, and melanomas, respectively. Here, we generated knockout mouse models for each of these three cyclin-dependent kinase inhibitors using engineered nucleases. The p16Ink4a and p19Arf knockout mice were generated via transcription activator-like effector nucleases (TALENs), and p27Kip1 knockout mice via clustered regularly interspaced short palindromic repeats/CRISPR-associated nuclease 9 (CRISPR/Cas9). These gene editing technologies were targeted to the first exon of each gene, to induce frameshifts producing premature termination codons. Unlike preexisting embryonic stem cell-based knockout mice, our mouse models are free from selectable markers or other external gene insertions, permitting more precise study of cell cycle-related diseases without confounding influences of foreign DNA. Keywords: TALEN, CRISPR/Cas9, cyclin-dependent kinase inhibitor Received 20 October 2018; Revised version received 7 December 2018; Accepted 8 December 2018 The cell cycle constitutes a series of events required proteins can cause severe disease [16,25,33].
    [Show full text]
  • CRISPR-Based Editing Techniques for Genetic Manipulation of Primary T Cells
    Review CRISPR-Based Editing Techniques for Genetic Manipulation of Primary T Cells Mateusz Kotowski and Sumana Sharma * MRC Human Immunology Unit, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, UK; [email protected] * Correspondence: [email protected] Received: 15 October 2020; Accepted: 14 November 2020; Published: 18 November 2020 Abstract: While clustered regularly interspaced short palindromic repeats (CRISPR)-based genome editing techniques have been widely adapted for use in immortalised immune cells, efficient manipulation of primary T cells has proved to be more challenging. Nonetheless, the rapid expansion of the CRISPR toolbox accompanied by the development of techniques for delivery of CRISPR components into primary T cells now affords the possibility to genetically manipulate primary T cells both with precision and at scale. Here, we review the key features of the techniques for primary T cell editing and discuss how the new generation of CRISPR-based tools may advance genetic engineering of these immune cells. This improved ability to genetically manipulate primary T cells will further enhance our fundamental understanding of cellular signalling and transcriptional networks in T cells and more importantly has the potential to revolutionise T cell-based therapies. Keywords: primary T cells; CRISPR/Cas9; genome-editing; CAR-T cells 1. Introduction In recent years, clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR- associated protein 9 (Cas9)-based techniques have transformed our ability to genetically manipulate mammalian genomes. Among the many fields within biomedical research to benefit from the ease of genetic manipulation using the CRISPR/Cas9 system is the study of the immune system and especially T cells.
    [Show full text]
  • Generating Mouse Models for Biomedical Research: Technological Advances Channabasavaiah B
    © 2019. Published by The Company of Biologists Ltd | Disease Models & Mechanisms (2019) 12, dmm029462. doi:10.1242/dmm.029462 AT A GLANCE Generating mouse models for biomedical research: technological advances Channabasavaiah B. Gurumurthy1,2 and Kevin C. Kent Lloyd3,4,* ABSTRACT recombination in embryonic stem cells has given way to more refined Over the past decade, new methods and procedures have been methods that enable allele-specific manipulation in zygotes. We also developed to generate geneticallyengineered mouse models of human highlight advances in the use of programmable endonucleases that disease. This At a Glance article highlights several recent technical have greatly increased the feasibility and ease of editing the mouse advances in mouse genome manipulation that have transformed genome. Together, these and other technologies provide researchers our ability to manipulate and study gene expression in the mouse. with the molecular tools to functionally annotate the mouse genome We discuss how conventional gene targeting by homologous with greater fidelity and specificity, as well as to generate new mouse models using faster, simpler and less costly techniques. 1Developmental Neuroscience, Munroe Meyer Institute for Genetics and KEY WORDS: CRISPR, Genome editing, Mouse, Mutagenesis Rehabilitation, University of Nebraska Medical Center, Omaha, NE 68106-5915, USA. 2Mouse Genome Engineering Core Facility, Vice Chancellor for Research Office, University of Nebraska Medical Center, Omaha, NE 68106-5915, USA. Introduction 3Department
    [Show full text]
  • Double-Strand Break Repair Pathways in Dna Structure-Induced Genetic Instability
    The Texas Medical Center Library DigitalCommons@TMC The University of Texas MD Anderson Cancer Center UTHealth Graduate School of The University of Texas MD Anderson Cancer Biomedical Sciences Dissertations and Theses Center UTHealth Graduate School of (Open Access) Biomedical Sciences 8-2010 DOUBLE-STRAND BREAK REPAIR PATHWAYS IN DNA STRUCTURE-INDUCED GENETIC INSTABILITY Diem T. Kha Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations Part of the Laboratory and Basic Science Research Commons Recommended Citation Kha, Diem T., "DOUBLE-STRAND BREAK REPAIR PATHWAYS IN DNA STRUCTURE-INDUCED GENETIC INSTABILITY" (2010). The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access). 76. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/76 This Thesis (MS) is brought to you for free and open access by the The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at DigitalCommons@TMC. It has been accepted for inclusion in The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access) by an authorized administrator of DigitalCommons@TMC. For more information, please contact [email protected]. DOUBLE-STRAND BREAK REPAIR PATHWAYS IN DNA STRUCTURE-INDUCED GENETIC INSTABILITY BY Diem Thi Kha, Bachelor of Science APPROVED: ______________________________ Karen M. Vasquez, Ph.D., Supervisory ______________________________
    [Show full text]
  • Manipulating the Mouse Genome Using Recombineering
    e in G net ts ic n E e n Biswas and Sharan, Adv Genet Eng 2013, 2:2 g m i e n c e e n DOI: 10.4172/2169-0111.1000108 r a i v n d g A Advancements in Genetic Engineering ISSN: 2169-0111 Review Article Open Access Manipulating the Mouse Genome Using Recombineering Kajal Biswas and Shyam K Sharan* Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland 21702, USA Abstract Genetically engineered mouse models are indispensable for understanding the biological function of genes, understanding the genetic basis of human diseases, and for preclinical testing of novel therapies. Generation of such mouse models has been possible because of our ability to manipulate the mouse genome. Recombineering is a highly efficient, recombination-based method of genetic engineering that has revolutionized our ability to generate mouse models. Since recombineering technology is not dependent on the availability of restriction enzyme recognition sites, it allows us to modify the genome with great precision. It requires homology arms as short as 40 bases for recombination, which makes it relatively easy to generate targeting constructs to insert, change, or delete either a single nucleotide or a DNA fragment several kb in size; insert selectable markers or reporter genes; or add epitope tags to any gene of interest. In this review, we focus on the development of recombineering technology and its application to the generation of genetically engineered mouse models. High-throughput generation of gene targeting vectors, used to construct knockout alleles in mouse embryonic stem cells, is now feasible because of this technology.
    [Show full text]